| Literature DB >> 23828338 |
Leonardo P Franchi1, Nilza N Guimarães, Laise R De Andrade, Heloísa H R De Andrade, Maurício Lehmann, Rafael R Dihl, Kênya S Cunha.
Abstract
Noni, a Hawaiian name for the fruit of Morinda citrifolia L., is a traditional medicinal plant from Polynesia widely used for the treatment of many diseases including arthritis, diabetes, asthma, hypertension and cancer. Here, a commercial noni juice (TNJ) was evaluated for its protective activities against the lesions induced by mitomycin C (MMC) and doxorrubicin (DXR) using the Somatic Mutation and Recombination Test (SMART) in Drosophila melanogaster. Three-day-old larvae, trans-heterozygous for two genetic markers (mwh and flr3 ), were co-treated with TNJ plus MMC or DXR. We have observed a reduction in genotoxic effects of MMC and DXR caused by the juice. TNJ provoked a marked decrease in all kinds of MMC- and DXR-induced mutant spots, mainly due to its antirecombinagenic activity. The TNJ protective effects were concentration-dependent, indicating a dose-response correlation, that can be attributed to a powerful antioxidant and/or free radical scavenger ability of TNJ.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23828338 DOI: 10.1590/S0001-37652013000200008
Source DB: PubMed Journal: An Acad Bras Cienc ISSN: 0001-3765 Impact factor: 1.753